SCHEMBL14083673

SCHEMBL14083673

CCN(CC)c1ccc(NC(=O)c2ccc(-c3ncccc3Cl)c(F)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ MAPT P10636 4/20 0.51
▸ GFER P55789 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ TRPV1 Q8NER1 7/20 0.49
▸ MAPK1 P28482 2/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.48
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ GHSR Q92847 4/20 0.47
▸ TSHR P16473 1/20 0.45
▸ HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083771 0.87 ALDH1A1 (0.54) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL14083706 0.86 TRPV1 (0.54) KMT2AMEN1TRPV1KCNQ3KCNQ2
SCHEMBL14083094 0.86 MAPT (0.49) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL14084085 0.86 TRPV1 (0.62) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL14083707 0.86 TRPV1 (0.56) KMT2AMEN1TRPV1L3MBTL1KCNQ3
SCHEMBL14083635 0.86 TRPV1 (0.56) KMT2AMEN1TRPV1KCNQ3KCNQ2
SCHEMBL14083719 0.86 NPC1 (0.56) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL14083700 0.85 TP53 (0.55) KMT2AMEN1MAPTTRPV1L3MBTL1
SCHEMBL14083633 0.85 TRPV1 (0.54) ALDH1A1TRPV1NPC1RAB9AKCNQ3
SCHEMBL14083652 0.85 TRPV1 (0.57) MAPTTRPV1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 LMNA 2619/4885ALDH1A1 1577/4885KMT2A 4272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback